title: Carcinoid crisis during transesophageal echocardiography.
authors.forename: M
authors.initials: M
authors.lastname: Janssen
authors.forename: E F
authors.initials: EF
authors.lastname: Salm
authors.forename: C S
authors.initials: CS
authors.lastname: Breburda
authors.forename: L J
authors.initials: LJ
authors.lastname: van Woerkens
authors.forename: W W
authors.initials: WW
authors.lastname: de Herder
authors.forename: C
authors.initials: C
authors.lastname: v/d Zwaan
authors.forename: J R
authors.initials: JR
authors.lastname: Roelandt
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D017548:Echocardiography, Transesophageal / Q000009:adverse effects*; D006801:Humans; D007650:Ketanserin / Q000627:therapeutic use; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000209:etiology* / Q000628:therapy; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use; D012702:Serotonin Antagonists / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D012702:Serotonin Antagonists; D007650:Ketanserin; D015282:Octreotide